Model for Quantitative Evaluation of Enzyme Replacement Treatment
Gaucher disease is the most frequent lysosomal disorder. Its enzyme replacement treatment was the new progress of modern biotechnology, successfully used in the last years. The evaluation of optimal dose of each patient is important due to health and economical reasons. The enzyme replacement is the...
Main Author: | Radeva B. |
---|---|
Format: | Article |
Language: | English |
Published: |
Academic Publishing House
2009-12-01
|
Series: | Bioautomation |
Subjects: | |
Online Access: | http://www.clbme.bas.bg/bioautomation/2009/vol_13.4/files/13.4_4.09.pdf |
Similar Items
-
EVALUATION OF ENZYME REPLACEMENT THERAPY EFFECTIVENESS IN CHILDREN WITH GAUCHER’S DISEASE ACCORDING TO THE INTERNATIONAL STUDIES
by: O. S. Gundobina, et al.
Published: (2014-05-01) -
Study of enzyme replacement therapy for Gaucher Disease: comparative analysis of clinical and laboratory parameters at diagnosis and after two, five and ten years of treatment
by: Ana Maria Almeida Souza, et al.
Published: (2014-10-01) -
A 20-Year Longitudinal Study of Plasma Chitotriosidase Activity in Treated Gaucher Disease Type 1 and 3 Patients—A Qualitative and Quantitative Approach
by: Paulina Szymańska-Rożek, et al.
Published: (2023-02-01) -
Alpha-Synuclein mRNA Level Found Dependent on L444P Variant in Carriers and Gaucher Disease Patients on Enzyme Replacement Therapy
by: Paweł Dubiela, et al.
Published: (2023-04-01) -
Long- and Short-Term Glucosphingosine (lyso-Gb1) Dynamics in Gaucher Patients Undergoing Enzyme Replacement Therapy
by: Pawel Dubiela, et al.
Published: (2024-07-01)